Royalty Pharma (RPRX) reported Q2 net income Wednesday of $18 million, compared with $32 million a year earlier.
Total income and other revenue for the quarter ended June 30 were $674 million, compared with $579 million a year earlier.
Royalty Pharma (RPRX) reported Q2 net income Wednesday of $18 million, compared with $32 million a year earlier.
Total income and other revenue for the quarter ended June 30 were $674 million, compared with $579 million a year earlier.
Comments